Grifols Stock News

DUBLIN--(BUSINESS WIRE)--The "Global Bleeding Disorder Treatment Market (2021-2026) by Type, Drug Class, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com''s offering. The Global Bleeding Disorder Treatment Market is estimated to be USD 13.5 Bn in 2021 and is expected to reach USD 18.6 Bn by 2026, growing at a CAGR of 10%. The factors driving the growth of the bleeding disorder treatment market a

Crossmark Global Holdings Inc. purchased a new position in shares of Grifols, S.A. (NASDAQ:GRFS) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 755,784 shares of the biotechnology companys stock, valued at approximately $11,042,000. Crossmark Global Holdings Inc. owned []

Grifols, S.A. (NASDAQ:GRFS)’s share price reached a new 52-week low during mid-day trading on Monday . The company traded as low as $10.21 and last traded at $10.28, with a volume of 32985 shares trading hands. The stock had previously closed at $10.51. GRFS has been the topic of several recent research reports. Citigroup raised […]

Key Prominent Players Covered in the Plasma Fractionation Market Research Report Are CSL (U.S.) , Grifols, S.A(Spain) , Baxter (U.S.) , Kedrion S.p.A (Italy) , Octapharma (Switzerland) , Shire- Part of Takeda Pharmaceutical Company Limited (U.S.) , Biotest AG (Germany) , LFB (France) Key Prominent Players Covered in the Plasma Fractionation Market Research Report Are CSL (U.S.) , Grifols, S.A(Spain) , Baxter (U.S.) , Kedrion S.p.A (Italy) , Octapharma (Switzerland) , Shire- Part of Takeda Pharmaceutical Company Limited (U.S.) , Biotest AG (Germany) , LFB (France)

Global Nucleic Acid Amplification Market Synopsis: It gets easy to make informed decisions that eventually provide maximum ROI from the marketing expenditures with the winning Nucleic Acid Amplification Market report. A well-equipped global delivery center and highly-competent research team leads to

The report on the global Immunoglobulin market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that

Subcutaneous Immunoglobulin is used for treatment of primary immunodeficiency diseases, secondary immunodeficiency diseases, and others. Subcutaneous immunoglobulins are efficacious, well-tolerated, have a favorable safety profile, and are suitable for all patients where clinically appropriate. Subcutaneous immunoglobulins are preferred to intravenous

Plasma Protein Products Market 2021 this report is including with the COVID19 Outbreak Impact analysis of key points influencing the growth of the market. Also, Plasma Protein Products Market (By major key players, By Types, By Applications, and Leading Regions)

Grifols S.A. (NASDAQ:GRFS) shares, rose in value on Friday, 11/26/21, with the stock price down by -5.13% to the previous days close as strong demand from buyers drove the stock to $10.91. Actively observing the price movement in the last trading, the stock closed the session at $11.50, falling within a range of $10.86 and Grifols S.A. (NASDAQ: GRFS) Stock Price Forecast: $100 Read More »

Northern Trust Corp lowered its stake in shares of Grifols, S.A. (NASDAQ:GRFS) by 26.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 108,233 shares of the biotechnology companys stock after selling 38,014 shares during the period. Northern Trust Corps holdings in Grifols were worth $1,878,000 []

Parametric Portfolio Associates LLC grew its position in shares of Grifols, S.A. (NASDAQ:GRFS) by 18.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 879,324 shares of the biotechnology company’s stock after acquiring an additional 138,540 shares during the period. Parametric Portfolio Associates LLC owned about 0.13% of […]

The global Human Rabies Immunoglobulin (IM) market was valued at 27.93 Million USD in 2020 and will grow with a CAGR of 7.34% from 2021 to 2027. According to a research report performed by Infinity Business Insights analysts, the Human

Lapides Asset Management LLC boosted its holdings in shares of Grifols, S.A. (NASDAQ:GRFS) by 83.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 492,600 shares of the biotechnology companys stock after purchasing an additional 224,200 shares during the period. Grifols accounts for []

Overview Disposable Blood Bags are marketed under government contracts and appropriations through the tendering procedure at public hospitals and federal blood banks. Disposable Blood Bags are also in high demand among privately financed hospitals, clinics, and blood banks. Throughout blood donation

According to the new report released, the global intravenous solution market was valued at US$ 8,372.0 million in 2019 and is expected to grow at a CAGR of 6.1 % during the forecast period of 2019-2027. Increasing prevalence of kidney